U.S. Ketamine Clinics Market Size, Share, & Trends Analysis Report By Treatment (Depression, Anxiety, PTSD, Others), By Therapy (On-site Therapy, Online Therapy), And Segment Forecasts, 2024 - 2030

July 2024 | 100 pages | ID: U070ACB8B17DEN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within Immediate

U.S. Ketamine Clinics Market Growth & Trends

The U.S. ketamine clinics market size is anticipated t%li%reach USD 6.90 billion by 2030, exhibiting a CAGR of 10.60% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The market's growth can be attributed t%li%the increase in mental health awareness, the ongoing opioid crisis, and an increasing number of ketamine clinics across the U.S. According t%li%SAMHSA, in 2022, about 19.86% of adults, which is nearly 50 million people, had some form of mental illness, with 4.91% experiencing severe mental health conditions. The prevalence of mental illness varied by state, ranging from 16.37% in New Jersey t%li%26.86% in Utah.

Moreover, the COVID-19 pandemic had a negative impact on the mental health of adults, leading t%li%an increased demand for innovative treatments. A survey by the Kaiser Family Foundation found that 39.3% of adults in the U.S. reported symptoms of anxiety or depressive disorder in February 2021, a significant increase from pre-pandemic levels. This increase in mental health issues has created the need for effective and rapid treatments, further driving the growth of the market in the U.S.

Moreover, the growing consolidation of local service providers with major ketamine clinic providers t%li%offer ketamine treatments in the U.S. is expected t%li%increase opportunities in the market. Market players are undertaking various strategic initiatives t%li%increase their capabilities, improve competencies, and expand their service portfolios. For instance, in October 2023[, Nue Life Health was acquired by a venture studi%li%specializing in psychedelic healthcare. This acquisition aligned with the studio’s mission t%li%advance innovative treatments in the mental wellness space, particularly through the use of psychedelic therapies.

U.S. Ketamine Clinics Market Report Highlights

• Based on treatment, the depression segment held the largest market share in 2023. This can be attributed t%li%the growing number of American adults burdened with severe major depression.
• Based on therapy, the on-site therapy segment dominated the market with the largest market share in 2023 owing t%li%the growing acceptance of ketamine therapy for mental health disorders which has led t%li%an expansion of clinics in the U.S.
• In February 2024, Avesta Ketamine and Wellness entered int%li%a partnership with Veteran Affairs (VA) t%li%provide free ketamine therapy t%li%veterans across Maryland, Bethesda, Northern Virginia, and Washington DC. This initiative was expected t%li%help veterans with substance abuse disorder, chronic pain, anxiety, PTSD, and treatment-resistant depression.

Contents

CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
  1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
  1.4.1. Purchased Database
  1.4.2. GVR’s Internal Database
  1.4.3. Secondary Sources
  1.4.4. Primary Research
  1.4.5. Details of Primary Research
  1.4.6. Research Assumption
1.5. Information or Data Analysis
  1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
  1.7.1. Volume Price Analysis
1.8. Objectives
1.9. List of Secondary Sources
1.10. List of Abbreviations

CHAPTER 2. EXECUTIVE SUMMARY

2.1. U.S. Ketamine Clinics Market
  2.1.1. Market Snapshot
  2.1.2. Segment Snapshot
  2.1.3. Competitive Landscape Snapshot

CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
  3.3.1. Market Driver Analysis
    3.3.1.1. Growing demand for effective mental health treatments
    3.3.1.2. Growing acceptance of ketamine’s therapeutic potential
    3.3.1.3. Increasing investment and partnerships in ketamine clinics
  3.3.2. Market Restraint Analysis
    3.3.2.1. Potential side effects and risks associated with ketamine therapy
    3.3.2.2. Easy accessibility for alternative treatments
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
  3.5.1. Industry Analysis - Porter’s Five Forces Analysis
    3.5.1.1. Supplier power
    3.5.1.2. Buyer power
    3.5.1.3. Substitution threat
    3.5.1.4. Threat of new entrant
    3.5.1.5. Competitive rivalry
  3.5.2. PESTEL Analysis

CHAPTER 4. TREATMENT BUSINESS ANALYSIS

4.1. U.S. Ketamine Clinics Market: Treatment Movement Analysis
4.2. U.S. Ketamine Clinics Market: Treatment Segment Dashboard
4.3. Treatment Movement & Market Share Analysis, 2023 & 2030
4.4. U.S. Ketamine Clinics Market Estimates & Forecast, by Treatment
4.5. Depression
  4.5.1. Depression market, 2018 - 2030 (USD Million)
4.6. Anxiety
  4.6.1. Anxiety market, 2018 - 2030 (USD Million)
4.7. PTSD
  4.7.1. PTSD market, 2018 - 2030 (USD Million)
4.8. Others
  4.8.1. Others market, 2018 - 2030 (USD Million)

CHAPTER 5. THERAPY BUSINESS ANALYSIS

5.1. U.S. Ketamine Clinics Market: Therapy Movement Analysis
5.2. U.S. Ketamine Clinics Market: Therapy Segment Dashboard
5.3. Therapy Movement & Market Share Analysis, 2023 & 2030
5.4. U.S. Ketamine Clinics Market Estimates & Forecast, by Therapy
5.5. On-site Therapy
  5.5.1. On-site therapy market, 2018 - 2030 (USD Million)
5.6. Online Therapy
  5.6.1. Online therapy market, 2018 - 2030 (USD Million)

CHAPTER 6. COMPETITIVE LANDSCAPE

6.1. Company Categorization
6.2. Company Market Position Analysis
6.3. Strategy Mapping
  6.3.1. Partnership/Collaboration/Alliance
  6.3.2. New Service Launch
  6.3.3. Mergers & Acquisitions
  6.3.4. Others
6.4. Company Profiles/Listing
  6.4.1. NY Ketamine Infusions
    6.4.1.1. Overview
    6.4.1.2. Financial performance
    6.4.1.3. Service benchmarking
    6.4.1.4. Strategic initiatives
  6.4.2. Stella MSO LLC dba Field Trip Health
    6.4.2.1. Overview
    6.4.2.2. Financial performance
    6.4.2.3. Service benchmarking
    6.4.2.4. Strategic initiatives
  6.4.3. Ketamine Clinics Los Angeles
    6.4.3.1. Overview
    6.4.3.2. Financial performance
    6.4.3.3. Service benchmarking
    6.4.3.4. Strategic initiatives
  6.4.4. Klarity Clinic (Tebra Inc.)
    6.4.4.1. Overview
    6.4.4.2. Financial performance
    6.4.4.3. Service benchmarking
    6.4.4.4. Strategic initiatives
  6.4.5. Vitalitas Denver Ketamine Infusion Center
    6.4.5.1. Overview
    6.4.5.2. Financial performance
    6.4.5.3. Service benchmarking
    6.4.5.4. Strategic initiatives
  6.4.6. Mindbloom, Inc.
    6.4.6.1. Overview
    6.4.6.2. Financial performance
    6.4.6.3. Service benchmarking
    6.4.6.4. Strategic initiatives
  6.4.7. Nue Life Health (NueCo Holdings, P.B.C.)
    6.4.7.1. Overview
    6.4.7.2. Financial performance
    6.4.7.3. Service benchmarking
    6.4.7.4. Strategic initiatives
  6.4.8. Better U, Inc.
    6.4.8.1. Overview
    6.4.8.2. Financial performance
    6.4.8.3. Service benchmarking
    6.4.8.4. Strategic initiatives
  6.4.9. Innerwell (KBS, Inc.)
    6.4.9.1. Overview
    6.4.9.2. Financial performance
    6.4.9.3. Service benchmarking
    6.4.9.4. Strategic initiatives
  6.4.10. Klarisana Health
    6.4.10.1. Overview
    6.4.10.2. Financial performance
    6.4.10.3. Service benchmarking
    6.4.10.4. Strategic initiatives

List Of Tables

LIST OF TABLES


Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. ketamine clinics market revenue estimates and forecast, by treatment, 2018 - 2030 (USD Million)
Table 4. U.S. ketamine clinics market revenue estimates and forecast, by therapy, 2018 - 2030 (USD Million)

List Of Figures

LIST OF FIGURES


Fig. 1 Veterinary Imaging Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation And Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for commodity flow analysis of the animal health market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market value, 2023 (USD Billion)
Fig. 17 Ancillary market outlook, 2023
Fig. 18 Veterinary imaging market dynamics
Fig. 19 Number of U.S. households owning a pet, by type of animal 2023 - 2024 (Million)
Fig. 20 Demographics of American pet owners, based on generation, %, 2023
Fig. 21 Veterinary Imaging market: PORTER’s analysis
Fig. 22 Veterinary imaging market: PESTEL analysis
Fig. 23 Veterinary imaging market by product: Key takeaways
Fig. 24 Veterinary imaging market by product, market share, 2023 & 2030
Fig. 25 X-ray market, 2018 - 2030 (USD Million)
Fig. 26 Ultrasound market, 2018 - 2030 (USD Million)
Fig. 27 MRI market, 2018 - 2030 (USD Million)
Fig. 28 CT imaging market, 2018 - 2030 (USD Million)
Fig. 29 Video endoscopy market, 2018 - 2030 (USD Million)
Fig. 30 Veterinary imaging market by solutions: Key takeaways
Fig. 31 Veterinary imaging market by solutions, market share, 2023 & 2030
Fig. 32 Equipment market, 2018 - 2030 (USD Million)
Fig. 33 Accessories/Consumables market, 2018 - 2030 (USD Million)
Fig. 34 PACS market, 2018 - 2030 (USD Million)
Fig. 35 Veterinary imaging market by animal type: Key takeaways
Fig. 36 Veterinary imaging market by animal type, market share, 2023 & 2030
Fig. 37 Small animals market, 2018 - 2030 (USD Million)
Fig. 38 Large animals market, 2018 - 2030 (USD Million)
Fig. 39 Veterinary imaging market by application: Key takeaways
Fig. 40 Veterinary imaging market by application, market share, 2023 & 2030
Fig. 41 Orthopedics and traumatology market, 2018 - 2030 (USD Million)
Fig. 42 Oncology market, 2018 - 2030 (USD Million)
Fig. 43 Cardiology market, 2018 - 2030 (USD Million)
Fig. 44 Neurology market, 2018 - 2030 (USD Million)
Fig. 45 Respiratory market, 2018 - 2030 (USD Million)
Fig. 46 Dental application market, 2018 - 2030 (USD Million)
Fig. 47 Other application market, 2018 - 2030 (USD Million)
Fig. 48 Veterinary imaging market by end use: Key takeaways
Fig. 49 Veterinary imaging market by end use, market share, 2023 & 2030
Fig. 50 Veterinary clinics & hospitals market, 2018 - 2030 (USD Million)
Fig. 51 Other end-use market, 2018 - 2030 (USD Million)
Fig. 52 Veterinary imaging market revenue, by region, 2023 & 2030, (USD Million)
Fig. 53 Regional market share analysis, 2023 & 2030
Fig. 54 Regional marketplace: Key takeaways
Fig. 55 Regional marketplace: Key takeaways
Fig. 56 Regional marketplace: Key takeaways
Fig. 57 North America: SWOT analysis
Fig. 58 North America veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 U.S. veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Canada veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Europe: SWOT analysis
Fig. 64 Europe veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 UK veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Germany veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 France veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Italy veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Spain veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Denmark veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Netherlands veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Sweden veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Norway veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Poland veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Asia Pacific: SWOT analysis
Fig. 86 Asia Pacific veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 China veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Japan veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 India veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Australia veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 South Korea veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Thailand veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 99 Latin America: SWOT analysis
Fig. 100 Latin America veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Brazil veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Mexico veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Argentina veterinary imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 MEA: SWOT analysis
Fig. 108 MEA veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 South Africa veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Saudi Arabia veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 UAE veterinary imaging market, 2018 - 2030 (USD Million)
Fig. 115 Market participant categorization
Fig. 116 Heat map analysis
Fig. 117 Strategic framework